P D Mintz
Affiliation: University of Virginia
- Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood productsP D Mintz
Department of Pathology, University of Virginia Health System, Charlottesville, VA, USA
Bone Marrow Transplant 44:205-11. 2009..Implementation of these processes precludes the necessity for irradiating cellular blood components to prevent TA-GVHD...
- Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver diseasePaul D Mintz
Department of Pathology, University of Virginia, Charlottesville, 22908 0286, USA
Blood 107:3753-60. 2006..No differences were observed in use of blood components, clinical hemostasis, or safety. These results suggest PCT-FFP supported hemostasis in the treatment of acquired coagulopathy similarly to conventional FFP...
- Outstanding Scientist of the Year 2005: William Spotnitz, gifted scientist, inventor, and cardiothoracic and vascular surgeonPaul D Mintz
Division of Clinical Pathology, University of Virginia, PO Box 800286, Charlottesville VA 22908, USA
J Long Term Eff Med Implants 15:339-46. 2005
- Assessment of the correlation of platelet morphology with in vivo recovery and survivalPaul D Mintz
University of Virginia Health System, Charlottesville, Virginia 22908, USA
Transfusion 45:72S-80S. 2005..We evaluated a novel device, the NAPSAC (Noninvasive Assessment of Platelet Shape and Concentration), designed to determine noninvasively the proportion of discoid platelets in a stored concentrate, as well as platelet concentration...
- Fibrin sealant: clinical use and the development of the University of Virginia Tissue Adhesive CenterP D Mintz
University of Virginia Health Care System, Charlottesville 22908, USA
Ann Clin Lab Sci 31:108-18. 2001....
- Transfusion triggers for blood componentsP Clark
Blood Bank, Clinical Laboratories, and Department of Pathology, University of Virginia Health System, Charlottesville, Virginia 22908, USA
Curr Opin Hematol 8:387-91. 2001..The value of fresh frozen plasma components, both standard and sterilized, also requires elucidation...
- Evaluation of adenosine triphosphate and 2,3-diphosphoglycerate after twenty-four hours in red cells washed for neonatal transfusionU Wrotnowski
Department of Pathology, University of Virginia, Charlottesville
Vox Sang 54:71-3. 1988..The results indicate that there is no difference in red cell ATP and 2,3-DPG concentrations between PRBC and WRBC after a 24-hour period...
- Imported platelets demonstrate decreased pH and glucose by reagent strip testing when compared to locally derived plateletsPamela Clark
Department of Pathology, University of Virginia Health Sciences Center, Clinical Laboratories, Charlottesville, VA 22908, USA
Ann Clin Lab Sci 36:443-6. 2006..None was found to be bacterially contaminated. In summary, imported platelet components were significantly more likely to be falsely reactive by reagent strip screening as compared to locally prepared platelet components...
- Things heat up for a cold agglutinin screen sampleAlison E Presley
Department of Pathology, University of Virginia Health System, Charlottesville, Virginia 22908 0214, USA
Transfusion 47:361. 2007
- Cardiovascular collapse during living-directed orthotopic liver transplantation associated with the transfusion of contaminated red blood cellsEdward C Nemergut
Department of Anesthesiology, University of Virginia Health System, Charlottesville, VA 22908, USA
J Cardiothorac Vasc Anesth 21:870-2. 2007
- Bacterial detection and extended platelet storage: the next step forwardRichard J Benjamin
Transfusion 45:1832-5. 2005
- Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patientsRichard J Benjamin
Joint Program in Transfusion Medicine, Brigham and Women s Hospital, Boston, Massachusetts, USA
Transfusion 45:1739-49. 2005..A randomized, double-blind trial is reported of the clinical efficacy of red blood cells (RBCs) treated for pathogen inactivation with S-303, a synthetic labile alkylating agent...
- TRANSFUSION's public access policyPaul M Ness
Transfusion 45:1700. 2005
- Blood use in cerebrovascular neurosurgeryDaniel E Couture
Department of Neurosurgery, University of Virginia, Health Sciences Center, Charlottesville, USA
Stroke 33:994-7. 2002..More blood is ordered than is actually transfused, and considerable variability exists between different institutions. We determine the use of blood transfusion in cerebrovascular surgery to develop a rational blood ordering practice...
- A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraPaul D Mintz
University of Virginia Health System, Charlottesville, Virginia, USA
Transfusion 46:1693-704. 2006....
- Hyperhemolysis syndrome: a relative contraindication for transfusionRommel P Lu
Division of Transfusion Medicine, Department of Pathology, University of Virginia, Charlottesville, VA 22908, USA
J Hosp Med 3:78-80. 2008